Skip to content
Screener

AbbVie ABBV Other income, net (Note 6)

Other income, net (Note 6) at other companies

Pfizer logo
PfizerPFE
$3.72B+603%
Johnson & Johnson logo
Johnson & JohnsonJNJ
-$331M-209%
Cardinal Health logo
Cardinal HealthCAH
-$16M-278%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$24.3M+84.1%
Incyte logo
IncyteINCY
$6.28M-14.1%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
-$1K-100%

Other financials

Income statement

See full
Revenue$17.0B+10.2%
Gross profit$12.7B+14.6%
Operating income$6.4B+31.4%
Net income$3.6B+285%
EPS (diluted)$2.03+290%

Balance sheet

See full
Cash & equivalents$9.4B+81.5%
Total debt$62.4B+1.8%
Total equity-$6.7B-569%
Total assets$136.46B+0.2%

Cash flow

See full
Operating cash flow$3.8B+134%
CapEx$265.0M+12.8%
Free cash flow$3.6B+155%

Valuation

See full
Market cap$430.95B+24.3%
P/E68.3×-23.9×
P/S6.7×+0.7×

Profitability

See full
Gross margin71.5%+0.5pp
Operating margin26.2%
Net margin9.8%+3.3pp
FCF margin31.8%+5.0pp

Returns & leverage

See full
Return on equity89%+32.7pp
Debt / equity46.6×+38.6×
Current ratio0.8×0.0×

Where this comes from

Reported directly by AbbVie in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The source filing: AbbVie’s 8-K, filed July 31, 2026. Open the filing →

Filed
Jul 31, 2026, 7:51 AM EDT
Accession
0001551152-26-000023

FAQ

What is AbbVie's other income, net (note 6)?
AbbVie (ABBV) reported other income, net (note 6) of $1.48B in Q2 2026.
How has AbbVie's other income, net (note 6) changed year-over-year?
AbbVie's other income, net (note 6) increased by 155.9% year-over-year, from -$2.64B to $1.48B.
What is the long-term trend for AbbVie's other income, net (note 6)?
Over 4 years (2021 to 2025), AbbVie's other income, net (note 6) has grown at a 23.4% compound annual growth rate (CAGR), from -$2.5B to -$5.8B.
What does other income, net (note 6) mean?
This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.

Ask your AI about AbbVie's other income, net (note 6).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude